Disposable Hospital Gowns Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Disposable Hospital Gowns Market Trends and Insights

Rising Surgical and Interventional Procedure Volumes

Surgical activity remains a key demand driver for the disposable hospital gowns market, as each procedure requires defined protective apparel. The outpatient channel is gaining importance as procedures shift from acute-care hospitals to ambulatory surgery centers (ASCs). CMS added 560 procedure codes to the ASC Covered Procedures List in its CY 2026 final rule, including cardiovascular, orthopedic, and spinal procedures. CMS also began a three-year phaseout of the Inpatient-Only List in 2026, supporting the migration of suitable procedures to outpatient facilities.^{[1]Centers for Medicare & Medicaid Services, “Calendar Year 2026 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Final Rule,” Centers for Medicare & Medicaid Services, cms.gov} These facilities require product assortments, packaging formats, and delivery schedules that differ from traditional hospital purchasing models. Higher-acuity procedures performed outside inpatient hospitals may require Level 3 or Level 4 barrier protection. 

Persistent Infection-Prevention and HAI-Control Requirements

Infection prevention continues to support demand in the disposable hospital gowns market, as gown performance remains central to clinical protection protocols. ANSI/AAMI PB70:2022 classifies protective apparel and drapes based on liquid barrier performance for healthcare facilities. The standard has increased the focus on documented barrier performance during product selection. Hospitals may place greater emphasis on test evidence and product certification when evaluating suppliers. A 2025 peer-reviewed study evaluated methods for testing the liquid barrier performance of disposable isolation gowns. Its findings reinforced the distinction between laboratory evaluations and real-world clinical use.^{[2]Michael Haberland et al., “Evaluating Disposable Isolation Gown Liquid Barrier Test Methods,” Biomedical Instrumentation & Technology, pmc.ncbi.nlm.nih.gov} Infection-control teams may require suppliers to provide stronger evidence of gown performance. This strengthens the role of testing, traceability, regulatory documentation, and quality systems in the disposable hospital gowns market.

Domestic PPE-Resilience Policies and Strategic Stockpiling

Public policy has shifted PPE resilience from emergency planning to routine procurement discussions across the disposable hospital gowns market. CMS released an Advance Notice of Proposed Rulemaking in January 2026 seeking input on strengthening domestic supply chains for PPE and essential medicines.^{[3]Centers for Medicare & Medicaid Services, “CMS Seeks Public Input on Strengthening Domestic Supply Chain for PPE, Essential Medicines,” Centers for Medicare & Medicaid Services, cms.gov} The proposal included a Secure American Medical Supplies designation for eligible hospitals. It also identified potential Medicare payment incentives linked to domestic sourcing thresholds. The U.S. Department of Veterans Affairs linked its Medical and Surgical Prime Vendor Program to requirements under the Make PPE in America Act. The United Kingdom also announced GBP 1 billion in health-protection investment during 2025 under its pandemic strategy. 

Procurement Shift Toward Verified Barrier Performance and Traceability

Healthcare buyers are placing less emphasis on the lowest unit price when products lack documented barrier performance. This shift directs supplier evaluation toward verified testing, regulatory history, and quality systems. Regulatory qualification may require detailed product documentation and validated test records. Suppliers with reliable technical documentation can strengthen their position in hospital tenders. Public buyers are also incorporating product traceability and waste characteristics into tender specifications. The revised EU Waste Framework Directive entered into force on October 16, 2025, establishing an extended producer responsibility framework for textiles in the European Union.

Volatility in Polypropylene and Other Nonwoven Input Costs

Polypropylene resin accounts for 60% to 70% of nonwoven conversion costs for manufacturers in the disposable hospital gowns market. Resin price volatility can compress margins under fixed-price supply contracts, particularly when converters cannot pass higher material costs to hospital customers. Long-term group purchasing organization contracts can restrict price revisions, while spot-market purchases can increase short-term costs during supply disruptions. Smaller regional manufacturers are more exposed due to limited purchasing scale and reduced access to long-term supply arrangements. Product performance variability creates an additional commercial constraint in the disposable hospital gowns market. Low-cost products with inconsistent barrier performance can increase buyer testing and qualification requirements. 

Sustainability Pressure From Single-Use Medical Waste

Single-use medical waste remains a growing concern for healthcare providers and suppliers in the disposable hospital gowns market. A 2025 mixed-methods study assessed reusable drapes and gowns across 134 countries and included data from 5,230 perioperative professionals. The study reported that reusable gowns generated 66% fewer greenhouse gas emissions and 84% less solid waste per 1,000 uses than disposable alternatives. These findings can influence procurement decisions among health systems pursuing lower-waste operating room practices. The revised EU Waste Framework Directive increased attention on post-use textile management. EURATEX and other European associations requested the clear exclusion of PPE and medical devices from the textile extended producer responsibility scope, reflecting concerns about products regulated for health and safety purposes.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Chemotherapy Gowns Support a Higher-Acuity Product Mix

Surgical gowns held 49.88% of global revenue in 2025, making them the leading product category in the disposable hospital gowns market. Their use spans elective orthopedic procedures, emergency interventions, cardiovascular care, and other surgical settings requiring higher barrier protection to maintain a sterile field. ANSI/AAMI PB70:2022 provides the liquid barrier classification framework for protective healthcare apparel. Non-surgical isolation, patient, examination, and dignity gowns remain essential for routine procurement across general wards, outpatient clinics, long-term care facilities, diagnostic settings, and patient-contact environments.

Chemotherapy gowns are the fastest-growing product category, with a forecast CAGR of 14.52% during 2026-2031. USP <800> identifies polyethylene-coated polypropylene or equivalent materials tested under ASTM D6978 for hazardous-drug handling, differentiating these gowns from standard surgical and isolation products. As oncology services expand, hospitals and community care settings are formalizing hazardous-drug safety procedures beyond specialized cancer centers. This trend increases demand for compliant gowns and creates a premium product category with specific material and testing requirements.

By Sterility: Sterile Gowns Combine Revenue Leadership With Strong Growth

Sterile disposable gowns held 64.67% of revenue in 2025 and led the sterility category. Healthcare providers use them in procedures requiring aseptic conditions and enhanced protection against fluid and microbial penetration, particularly Level 3 and Level 4 barrier procedures. Their performance requirements and sterilization processes support higher unit prices. Non-sterile gowns remain necessary in general wards, diagnostic laboratories, and long-term care settings, particularly in budget-sensitive procurement environments.

Sterile disposable gowns are forecast to grow at a 15.20% CAGR during 2026-2031, the highest rate in the sterility category. EN 13795-1:2025 covers surgical drapes, gowns, and clean air suits used as medical devices and introduced a high-performance tier. The tier requires a wet microbial penetration barrier index IB of at least 6.0 and liquid penetration resistance of at least 100 cm H₂O in critical zones. European hospitals renewing supply contracts after the 2025 regulatory update need to assess compliance, supporting demand for higher-value sterile gowns.

By Material: Polyethylene-Coated Nonwoven Gains From Specialized Protection Requirements

Polypropylene nonwoven held 56.76% of material revenue in the disposable hospital gowns market in 2025. It remains the leading material due to its cost efficiency, broad design compatibility, and suitability for products meeting AAMI Level 1 to Level 3 protection requirements. Large nonwoven conversion capacity in China, the United States, and Germany supports stable availability. Polyethylene film, microporous film laminates, and polyethylene-polypropylene composites address applications with higher liquid barrier requirements.

Polyethylene-coated nonwoven is forecast to grow at a 13.55% CAGR during 2026-2031. USP <800> identifies polyethylene-coated polypropylene as a reference construction for chemotherapy gowns used in hazardous-drug compounding and administration. SMS constructions combine spunbond outer layers with a meltblown barrier layer to balance breathability and fluid protection. Material innovation supports compliance with clinical requirements while maintaining usability for healthcare staff.

By End User: Ambulatory Surgery Centers Create New Supply Requirements

Hospitals held 53.24% of revenue in 2025 and represented the largest end-user group. They perform high-acuity procedures, including cardiac surgery, transplantation, and trauma care, which often require higher-value Level 3 or Level 4 gowns. Centralized supply chains and group purchasing organizations commonly manage hospital procurement, favoring suppliers with reliable distribution and broad product portfolios. Physician offices, outpatient clinics, diagnostic laboratories, and long-term care facilities provide a stable demand base for lower-barrier products.

Ambulatory surgery centers are forecast to grow at a 13.87% CAGR during 2026-2031. CMS made 560 additional codes eligible for ASC treatment under the CY 2026 final rule, including cardiac ablation and lumbar spinal fusion. The shift toward higher-acuity outpatient procedures increases demand for stronger barrier apparel and specialized gown solutions. ASC customers may require smaller orders, faster replenishment, and broader SKU availability, creating opportunities for suppliers with ASC-focused logistics capabilities.

Geography Analysis

North America held 39.56% of global revenue in 2025, making it the largest regional market. High gown usage per procedure, established group purchasing systems, stringent barrier-performance requirements, and the concentration of complex surgical care supported demand. In January 2026, CMS sought comments on strengthening domestic supply chains for PPE and essential medicines, including the Secure American Medical Supplies designation and potential Medicare payment incentives. The VA also applied domestic-content requirements through its Medical and Surgical Prime Vendor Program, while Canada and Mexico contributed through publicly funded healthcare systems and expanding outpatient surgical capacity.

Europe’s disposable hospital gowns market was shaped by evolving technical standards and waste-management policies. Commission Implementing Decision (EU) 2025/2078 addressed harmonized standards for surgical clothing, drapes, medical face masks, and sterilizers in October 2025, increasing compliance requirements for sterile surgical gowns marketed as medical devices. Germany, France, and the United Kingdom faced supply contract renewals, while the revised Waste Framework Directive increased the focus on producer responsibility for textile products. Hospital construction supported demand in Saudi Arabia and the UAE, while public hospital investments supported Brazil and Argentina despite currency volatility and reliance on imported nonwoven inputs.

Asia-Pacific is forecast to grow at a CAGR of 14.77% from 2026 to 2031, making it the fastest-growing region. China and India are expanding hospital infrastructure and domestic manufacturing capacity for operating room consumables. China’s GB 19082-2024 standard aligned with AAMI Level 4 requirements, raising the quality baseline for protective products. In May 2026, Winner Medical broke ground on a USD 60 million, 93,000-square-meter production facility in Quang Ninh Province, Vietnam, with Phase I focused on advanced medical dressings and operating room consumables. Japan and South Korea remain key premium markets, where public tenders increasingly prioritize quality-system certification and performance specifications.